Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Percheron Therapeutics.
RELATED STOCKHEAD STORIES
Experts
Money Talks: Here are 3 biotechs chasing the dream
Health & Biotech
Prescient, Antisense the only green shoots in a sea of red
Experts
Scopo’s health powerplays: The cash caboose keeps rolling on
Experts
Scopo’s health powerplays: Markets are getting back to normal
Health & Biotech
Check up: Making it in America
News
Closing Bell: Today’s biggest small cap movers on the ASX
Experts
ScoPo’s health powerplays: The transition to greatest
News
Lunchtime ASX small cap wrap: Who’s planning to expand their control today?
Health & Biotech
Biotech: Antisense opens up 89pc after smashing DMD clinical trial
News
10 at 10: These ASX stocks are shooting hoops this morning
News
Rise and Shine: What you need to know before the ASX opens
Experts
ScoPo’s health powerplays: Cap raises goin’ crazy
Health & Biotech
Medtech stocks are on the radar, and this analyst thinks the sector has further to run
Health & Biotech
Health: Biotron targets coronavirus, shares jump
Health & Biotech
Health Kick Podcast: Novel gene targeting therapies, protein disruptors and why ANP’s recent trial success have investors buzzing
Health & Biotech
Health: Antisense’s anti-muscular dystrophy drug just took a big step
Health & Biotech
